[Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
作者信息
Dolfus Hélène, Lévy Nicolas
出版信息
Rev Prat. 2012 Jan;62(1):89-90.
PMID:22335076
Abstract
摘要
相似文献
1
[Rare diseases: an "exceptional field of research. Interview by Catherine Holué].[罕见病：“一个特殊的研究领域”。凯瑟琳·霍吕访谈]
Rev Prat. 2012 Jan;62(1):89-90.
2
[GPs: patients require you to doubt! Interview by Catherine Holué].[全科医生：患者需要你持怀疑态度！凯瑟琳·霍吕访谈]
Rev Prat. 2012 Jan;62(1):85-6.
3
[Rare diseases: "a public health priorty". Interview by Catherine Holué].[罕见病：“一项公共卫生重点事项”。凯瑟琳·霍吕访谈]
Rev Prat. 2012 Jan;62(1):79-80.
4
[Neuromuscular diseases are many but rare].神经肌肉疾病种类繁多但较为罕见。
Lakartidningen. 2013;110(15):752-3.
5
[Health technology assessment in the field of rare diseases at Haute Autorité de Santé in France].[法国高等卫生管理局在罕见病领域的卫生技术评估]
Med Sci (Paris). 2018 May;34 Hors série n°1:49-50. doi: 10.1051/medsci/201834s126. Epub 2018 Jun 18.
6
7
Rare pulmonary diseases: a common fight.罕见肺部疾病：共同的战斗。
Eur Respir Rev. 2017 Sep 6;26(145). doi: 10.1183/16000617.0059-2017. Print 2017 Sep 30.
8
[The stakes of pre- and post-market authorization development and clinical assessment].[上市前和上市后授权开发及临床评估的风险]
Presse Med. 2012 May;41 Suppl 1:S6-8. doi: 10.1016/j.lpm.2012.02.026. Epub 2012 Apr 6.
9
[Rare diseases are not orphan any longer].罕见病不再是孤儿病。
Rev Prat. 2012 Jan;62(1):3.
10
Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.日本罕见病临床研究促进临床试验网络：肌营养不良临床试验网络
BMC Health Serv Res. 2016 Jul 11;16:241. doi: 10.1186/s12913-016-1477-4.
引用本文的文献
1
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.抗磷脂综合征临床试验和国际网络联盟（APS ACTION）：10 年更新。
Curr Rheumatol Rep. 2021 May 1;23(6):45. doi: 10.1007/s11926-021-01008-8.
Zotero 插件